Huang T F, Yeh C H, Wu W B
Pharmacological Institute, College of Medicine, National Taiwan University, No. 1 Jen-Ai Road, Sec. 1, Taipei, Taiwan, ROC.
Haemostasis. 2001 May-Dec;31(3-6):192-206. doi: 10.1159/000048063.
Angiogenesis is a complex process consisting of the proliferation, migration and differentiation of endothelial cells, and it is essential for the progression of malignant solid tumors. In this report, we examine the effects of disintegrins (e.g. rhodostomin and accutin) and glycoprotein-lb-binding proteins (e.g. agkistin) on each step in angiogenesis using in vitro and in vivo models. Rhodostomin (but not agkistin) inhibited the viability of human umbilical vein endothelial cells (HUVECs) and capillary tube formation of HUVECs. Rhodostomin also inhibited HUVEC migration and invasion evoked by basic fibroblast growth factor (bFGF). In in vivo studies, rhodostomin inhibited bFGF-, but not vascular-endothelial-growth-factor (VEGF)- associated angiogenesis in chick chorioallantoic membrane model, blocked both bFGF and B16F10 melanoma cell-induced neovascularization, and suppressed the growth of subcutaneously inoculated B16F10 solid tumor, leading to a prolonged survival of the C57BL/6 mice treated with rhodostomin. The antiangiogenic effects of rhodostomin on bFGF-treated HUVECs may be mainly related to the blockade of the interaction of endothelial alpha(v)beta(3) and extracellular matrix.
血管生成是一个复杂的过程,由内皮细胞的增殖、迁移和分化组成,对恶性实体瘤的进展至关重要。在本报告中,我们使用体外和体内模型研究了去整合素(如罗豆素和蛇毒抗凝蛋白)和糖蛋白-lb结合蛋白(如银环蛇毒素)对血管生成各步骤的影响。罗豆素(而非银环蛇毒素)抑制人脐静脉内皮细胞(HUVECs)的活力以及HUVECs的毛细血管管腔形成。罗豆素还抑制碱性成纤维细胞生长因子(bFGF)诱导的HUVEC迁移和侵袭。在体内研究中,罗豆素在鸡胚绒毛尿囊膜模型中抑制bFGF相关的血管生成,但不抑制血管内皮生长因子(VEGF)相关的血管生成,阻断bFGF和B16F10黑色素瘤细胞诱导的新生血管形成,并抑制皮下接种的B16F10实体瘤的生长,从而延长了用罗豆素治疗的C57BL/6小鼠的生存期。罗豆素对bFGF处理的HUVECs的抗血管生成作用可能主要与阻断内皮α(v)β(3)与细胞外基质的相互作用有关。